Skip to main content
Advanced Biomed Inc. logo

Advanced Biomed Inc. — Investor Relations & Filings

Ticker · ADVB ISIN · US00752P1049 US Professional, scientific and technical activities
Open in API
Filings indexed 85 across all filing types
Latest filing 2024-01-19 Regulatory Filings
Country US United States of America
Listing US ADVB

About Advanced Biomed Inc.

http://www.advanbiomed.com/

Advanced Biomed Inc. is a company specializing in the research, development, and commercialization of advanced diagnostic systems for precision oncology. The company focuses on developing proprietary microfluidic biochip technologies that integrate semiconductor and biotechnology principles. Its platform provides assay products and services that cover the full spectrum of cancer care, including early screening, detection, diagnosis, staging, and treatment selection. A key technology involves diagnostic devices that capture circulating tumor cells through physical trapping, offering an alternative to traditional antibody-based methods. The company aims to provide rapid and affordable solutions to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2024
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the SEC Division of Corporate Finance responding to comments on an Amendment No. 10 to a Registration Statement on Form S-1. It discusses revisions and disclosures related to the Form S-1 registration statement, which is a filing used for securities registration, typically for IPOs or other offerings. The document is a correspondence letter responding to SEC comments rather than the registration statement itself or a financial report. It does not contain financial statements or substantive financial data but is a regulatory communication. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory correspondence and filings that do not fit other categories.
2024-01-19 English
FORM S-1/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It is related to an initial public offering (IPO) of common stock by Advanced Biomed Inc. The text includes detailed disclosures about the company, its subsidiaries, regulatory risks, and the offering itself. This type of filing is a capital markets registration statement used to register securities for sale to the public. It is not an earnings release, annual report, or any other financial report. It is also not a proxy, voting results, or management change announcement. The document is a capital/financing update related to the company's IPO process and securities registration.
2024-01-19 English
Regulatory Filings 2024
Regulatory Filings
2024-01-18 English
Regulatory Filings 2024
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the SEC Division of Corporate Finance responding to comments on an Amendment No. 9 to a Registration Statement on Form S-1. It discusses detailed comments and responses related to disclosures in the Form S-1 registration statement, which is a filing used for securities registration, typically for IPOs or other offerings. The document is not the registration statement itself but a correspondence letter responding to SEC staff comments. It does not contain financial statements or substantive financial data but is a regulatory correspondence related to a registration filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory correspondence and compliance documents that do not fit other categories.
2024-01-09 English
FORM S-1/A
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 10 to Form S-1, a registration statement filed with the SEC under the Securities Act of 1933. It is a preliminary prospectus for an initial public offering (IPO) of common stock by Advanced Biomed Inc. The text includes detailed disclosures about the company, its subsidiaries, regulatory risks, and the offering details. Form S-1 and its amendments are filings related to capital raising and securities registration for public offerings. This type of document is best classified under Capital/Financing Update (CAP) because it pertains to the registration and offering of new shares to the public, which is a capital raising activity. It is not an annual or quarterly report, audit report, or earnings release, nor is it a proxy or governance document. The length and content confirm it is a substantive filing, not just an announcement or certification.
2024-01-09 English
Regulatory Filings 2024
Regulatory Filings
2024-01-05 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.